Samsrita Labs Completes Q3 FY26 Financial Results Publication Under Regulation 47
Samsrita Labs Limited completed mandatory newspaper publication of Q3 FY26 financial results under Regulation 47, reporting significant loss widening to ₹335.56 lakhs from ₹4.05 lakhs in previous year, primarily driven by major intangible asset write-off worth ₹3.26 crore due to technological obsolescence.

*this image is generated using AI for illustrative purposes only.
Samsrita Labs Limited has completed the mandatory newspaper publication of its unaudited financial results for the third quarter of FY26, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company reported a substantial widening of losses for the quarter, with net loss reaching ₹335.56 lakhs compared to ₹4.05 lakhs in the corresponding quarter of the previous year.
Regulatory Compliance and Publication
The company published its financial results in Financial Express (English newspaper) and Nava Telangana (Telugu newspaper) on February 7, 2026. The publication included QR codes and webpage details where complete unaudited standalone and consolidated financial results are accessible to investors.
| Compliance Parameter: | Details |
|---|---|
| Publication Date: | February 7, 2026 |
| English Newspaper: | Financial Express |
| Regional Newspaper: | Nava Telangana (Telugu) |
| Board Approval Date: | February 6, 2026 |
| Regulation: | SEBI Regulation 47 |
Financial Performance Overview
The healthcare sector company's financial performance was significantly impacted by a major asset write-off during the quarter ended December 31, 2025. The primary driver of the increased losses was a significant write-off of intangible assets under development worth ₹3,25,95,369.
| Metric: | Q3 FY26 | Q3 FY25 | Change |
|---|---|---|---|
| Net Loss: | ₹335.56 lakhs | ₹4.05 lakhs | Increased significantly |
| Total Expenses: | ₹335.56 lakhs | ₹4.05 lakhs | Increased substantially |
| Employee Benefits: | ₹5.32 lakhs | ₹2.76 lakhs | +92.75% |
| Other Expenses: | ₹330.21 lakhs | ₹1.26 lakhs | Increased substantially |
| Basic EPS: | ₹(1.48) | ₹(0.03) | Declined |
Nine-Month Performance
The nine-month period ended December 31, 2025, showed similarly concerning trends with net loss reaching ₹856.72 lakhs compared to ₹17.25 lakhs in the previous year. The company's paid-up equity share capital stood at ₹2,274.97 lakhs as of December 31, 2025, compared to ₹1,480.87 lakhs in the previous year.
Asset Write-off Impact
The company stated that the intangible asset write-off was necessitated by technological obsolescence, as the underlying patents are no longer expected to provide future economic benefits. This write-off was recognized in the Statement of Profit and Loss for the quarter and represents a substantial one-time charge affecting the company's financial performance.
Board Approval and Accessibility
The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 6, 2026. The complete results are available on stock exchange websites ( www.bseindia.com and www.msei.in ) and the company's webpage, accessible through QR codes published in the newspapers. The results have been prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by statutory auditors.
Historical Stock Returns for Samsrita Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +3.47% | -2.82% | -6.59% | -4.45% | -48.64% |
































